ALPS Advisors’s Pharvaris PHVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-52,148
Closed -$1.47M 1207
2026
Q1
$1.47M Sell
52,148
-444
-0.8% -$11.9K 0.01% 466
2025
Q4
$1.46M Buy
+52,592
New +$1.27M 0.01% 461
2025
Q3
Sell
-29,398
Closed -$517K 1124
2025
Q2
$517K Sell
29,398
-7,235
-20% -$117K ﹤0.01% 625
2025
Q1
$575K Sell
36,633
-7,038
-16% -$119K ﹤0.01% 573
2024
Q4
$837K Buy
43,671
+1,363
+3% +$28.1K 0.01% 529
2024
Q3
$784K Buy
+42,308
New +$773K 0.01% 554

Other funds holding PHVS

ALPS Advisors's PHVS Position: Q2 2026 in Review

ALPS Advisors sold out of Pharvaris (PHVS) in Q2 2026, closing a stake of 52,148 shares — an estimated $1.47M sold.

ALPS Advisors first reported a position in PHVS in Q3 2024 and held it in 6 quarters. The position peaked at $1.47M in Q1 2026. 23 funds tracked by Wall St. Rank hold PHVS as of Q2 2026.

  • ALPS Advisors reported no remaining Pharvaris position as of Q2 2026 after selling out during the quarter.
  • ALPS Advisors sold 52,148 Pharvaris shares in Q2 2026, an estimated $1.47M.
  • ALPS Advisors first reported a position in Pharvaris in Q3 2024 and held it in 6 quarters.
  • ALPS Advisors's Pharvaris position peaked at $1.47M in Q1 2026.
  • 23 funds tracked by Wall St. Rank held Pharvaris as of Q2 2026.

Based on ALPS Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.